期刊文献+

对门诊老年2型糖尿病患者进行生活方式干预的效果评价 被引量:3

Efects of lifestyle intervention with metabolic control on out elderly type 2 diabetes patients
下载PDF
导出
摘要 目的探讨生活方式干预对老年2型糖尿病(T2DM)患者的疗效。方法选取60例在该院门诊接受正规降糖药物治疗的老年T2DM患者,按自愿的原则分为干预组和对照组,干预组采用生活方式干预(饮食控制、运动治疗)和药物治疗,对照组仅采用药物治疗,于治疗前及治疗后3个月复查患者体重指数、空腹血糖、餐后2h血糖、血脂、糖化血红蛋白。结果干预组患者治疗后的空腹血糖、餐后2h血糖、糖化血红蛋白、三酰甘油较治疗前改善,差异具有显著性(P<0.05),而对照组治疗后较治疗前的各项指标无明显改善。治疗前两组间比较,各项指标无明显差异;治疗后两组间比较,干预组患者空腹血糖、餐后2h血糖、糖化血红蛋白较对照组改善,差异具有显著性(P<0.05)。结论通过饮食控制、长期规律的量化运动等生活方式干预,可以有效地降低老年T2DM患者的血脂、血糖,使糖化血红蛋白显著下降,患者血糖水平获得较长时间的平稳控制,有利于延缓并发症的发生发展。 [Objective] To study the impact of lifestyle intervention for elderly type 2 diabetes patients. [Methods] Sixty out elderly type 2 diabetes mellitus (T2DM) patients, who were in regular hypoglycermic treating, were divided into study group and control group according to the patients' wishes. Patients in study group were treated in diet control and exercises and drug treatment while the control group only had drug treatment. Assessment of body mass index (BMI), fasting blood glucose (FBG), postprandial blood glueose(PBG), lipid, HbAle in both groups. [Result ] After lifestyle intervention, FBG, PPBG, triglyeride (TG) in study group were significantly lower than those before (P 〈0.05) for there is almost no changes in control group. There was no apparent difference between study group and control group before lifestyle intervention, but after, FBG, PPBG, HbAlc in study group were significantly lower than those in control group (P 〈0.05) for there is almost no change in control group either before or after. [ Conclusion] Lifestyle intervention can decrese lipid and blood glucose and HbAlc in elder patients with T2DM through diet control, long term and regular exercises. For it can keep the patients' BG in an appropriate and smooth lever, then delay the development of the complications.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第14期2190-2192,共3页 China Journal of Modern Medicine
关键词 老年 2型糖尿病 生活方式 干预 elder patient type 2 diabetes lifestyle intervention
  • 相关文献

参考文献6

二级参考文献11

共引文献170

同被引文献28

  • 1杨菊贤,殷兆芳.冠心病的预防策略与康复[J].心血管康复医学杂志,2005,14(5):422-425. 被引量:11
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 3CAMPBELL I W. The role of mefformin and pioglitazone in early combination treatment of type 2 diabetes mellitus[J]. British Journal of Diabetes &Vascular Disease, 2006,6 (5) : 207.
  • 4DESILETS A R. Role of Mefformin for weight management inpatients without type 2 diabetes[J]. The Annals of Pharmacotherapy, 2008,42 (6) : 817.
  • 5DE VOGLI R, FERRIE J E, CHANDOLA T, et al. Unfairness and health: evidence from the Whitehall II Study[J].J Epidemiol Community Health, 2007,61 : 513.
  • 6CARIN ALM-ROIJER, MARTIN S, GIGGI U, et al. Better knowledge improve adherence to lifestyle changes and medication in patients with coronary heart disease[JJ. European Society of Cardiology,2004, (3) :321.
  • 7DOMANSKI M, MITCHELL G, PFEFFER M, et al. Pulse pressure and cardiovascular disease related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) [J]. JAMA, 2002,287(20) :2677.
  • 8FRANKLIN S S, LARSON M G, KHAN S A, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study[J]. Circulation, 2001,103 : 1245.
  • 9ALMGREN T, PERSSON B, WILHELMSEN L, et al. Stroke and coronary heart disease in treated hypertension:a prospective cohort study[J]. J IntemMed, 2005,257 (6) : 496.
  • 10VELAZQUEZ E J, PFEFFER M A, MCMURRAY J V,et al. Valsartan in acute myiocardial infarction (VALIANT) trial: basehne characteristics in context[J]. Eur J Heart Fail,2003, 5:537.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部